Related Experiment Video
Updated: May 5, 2026
07:45
Orthotopic Transplantation of Breast Tumors as Preclinical Models for Breast Cancer
Published on: May 18, 2020
6.2K
Breast cancer in the elderly: which lessons have we learned?
Natalie Turner1, Elena Zafarana, Dimitri Becheri
1Sandro Pitigliani' Medical Oncology Unit, Department of Oncology, Hospital of Prato, Istituto Toscano Tumori, Piazza dell'Ospedale 2, Prato, Italy.
Future Oncology (London, England)
|December 4, 2013
Summary
Older breast cancer patients can benefit from adjuvant chemotherapy, but toxicity risks are higher. Treatment decisions should prioritize tumor biology and biological age over chronological age for better risk assessment.
Area of Science:
- Oncology
- Geriatric Medicine
- Clinical Pharmacology
Background:
- Adjuvant chemotherapy for older breast cancer patients lacks robust evidence, posing management challenges.
- Elderly women may experience significant benefits from adjuvant chemotherapy but face increased toxicity risks.
- Current treatment decisions often rely on chronological age, neglecting individual biological factors.
Purpose of the Study:
- To evaluate the benefits and risks of adjuvant chemotherapy in older breast cancer patients.
- To explore the role of biological age and tumor biology in treatment decision-making.
- To identify methods for assessing chemotherapy tolerance in elderly populations.
Main Methods:
- Review of existing evidence on adjuvant chemotherapy in older breast cancer patients.
- Analysis of factors influencing chemotherapy benefit and toxicity in elderly individuals.
- Discussion of geriatric assessment tools and frailty screening for oncology patients.
Main Results:
- Older women can achieve similar benefits from adjuvant chemotherapy as younger patients.
- Increased risk of toxicities is a key concern in elderly patients undergoing chemotherapy.
- Geriatric assessments can identify functional deficits impacting chemotherapy tolerance, though implementation is challenging.
Conclusions:
- Adjuvant chemotherapy decisions for older breast cancer patients should integrate tumor biology and biological age.
- Frailty screening tools are under development to aid in assessing chemotherapy suitability.
- Future research should focus on precise methods for determining biological age to optimize risk:benefit ratios.
Related Concept Videos
01:21Cancer Survival Analysis
870
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
870
02:59Cancer Prevention
6.5K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.5K
02:59Cancer Prevention
2.6K
2.6K
02:20Longitudinal Research
11.7K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
11.7K
01:30Cancer Vaccines
1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
01:15Drug Dosing: Geriatric Patients
400
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
400